Bjorn B. Thaler - Nov 15, 2022 Form 4 Insider Report for 1Life Healthcare Inc (ONEM)

Signature
/s/ Ivy Tseng, Attorney-in-Fact for Bjorn B. Thaler
Stock symbol
ONEM
Transactions as of
Nov 15, 2022
Transactions value $
-$78,851
Form type
4
Date filed
11/17/2022, 07:37 PM
Previous filing
Nov 3, 2022
Next filing
Dec 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONEM Common Stock Options Exercise +10.3K +70.8% 24.7K Nov 15, 2022 Direct F1
transaction ONEM Common Stock Sale -$66.1K -3.94K -15.91% $16.81 20.8K Nov 16, 2022 Direct F2, F3
transaction ONEM Common Stock Sale -$12.7K -761 -3.66% $16.70 20K Nov 17, 2022 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONEM Restricted Stock Units Options Exercise $0 -10.3K -25% $0.00 30.8K Nov 15, 2022 Common Stock 10.3K Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Restricted stock units convert into the issuer's common stock on a one-for-one basis.
F2 Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs"). This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person.
F3 This transaction was executed in multiple trades at prices ranging from $16.80 to $16.825. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
F5 The restricted stock units will vest annually over three years, with 25% of the restricted stock units vesting on each of the first and second anniversaries of the vesting commencement date and 50% of the restricted stock units vesting on the third anniversary of the vesting commencement date, subject to the reporting person's continuous service as of each such date.